NRG-BN003
Closed to Accrual
Protocol Information
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Principal Investigator
Leland Rogers
Status
Closed to Accrual
Open to Accrual
June 14, 2017
Closed to Accrual
September 28, 2026
Disease Site
Brain [BN] Benign Brain Tumors
Phase
III
Developmental Therapeutics
No
Primary Objective
The primary endpoint is progression-free survival (PFS). The principle objective is to determine the extent of clinical benefit of the addition of adjuvant radiotherapy (RT) to gross total resection (GTR) for patients with newly diagnosed World Health Organization (WHO) grade II meningioma.
Patient Population
Newly diagnosed gross totally resected (Simpson Grade 1-3) WHO grade II meningioma
Target Accrual
133
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
To learn more about this study, visit the Patient Study Webpage.
-
Share this study.
-
-
-
-
